戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 188 patients with coronary disease underwent intravascular ultrasonography.
2 ajor secondary efficacy measures assessed by intravascular ultrasonography.
3  stents, as assessed by both angiography and intravascular ultrasonography.
4  determined by gray-scale and radiofrequency intravascular ultrasonography.
5 ation of images obtained using CT, MRI, PET, intravascular ultrasonography and optical coherence tomo
6                                     Finally, intravascular ultrasonography and optical coherence tomo
7   A total of 543 patients underwent coronary intravascular ultrasonography and were randomized to rec
8 be classified on the basis of radiofrequency intravascular ultrasonography as thin-cap fibroatheromas
9 velopment of graft vascular disease (GVD) by intravascular ultrasonography at 1 year posttransplantat
10  or matching placebo, and underwent coronary intravascular ultrasonography at baseline (n = 839) and
11 sclerosis progression was measured by repeat intravascular ultrasonography examination in 360 patient
12 nvasive arterial imaging modalities, such as intravascular ultrasonography, have shown that reducing
13                          We performed serial intravascular ultrasonography in 1039 patients with coro
14                                 We performed intravascular ultrasonography in 408 patients with angio
15                                 We performed intravascular ultrasonography in 502 patients with angio
16 disease progression was measured by repeated intravascular ultrasonography in 910 patients (77%).
17                                              Intravascular ultrasonography is the preferred means to
18 from baseline to week 78, measured by serial intravascular ultrasonography (IVUS) imaging.
19 ex of microcirculatory resistance (IMR); and intravascular ultrasonography (IVUS) of the left anterio
20                                              Intravascular ultrasonography (IVUS), near-infrared spec
21                              The benefits of intravascular ultrasonography (IVUS)-guided percutaneous
22 que area divided by vessel area) measured by intravascular ultrasonography (IVUS).
23                                              Intravascular ultrasonography provides a unique opportun
24                                              Intravascular ultrasonography showed that the average in
25 dary efficacy variables assessed by means of intravascular ultrasonography showed unfavorable effects
26                                     By using intravascular ultrasonography, the arc lengths of the ou
27 uation, serial quantitative angiography, and intravascular ultrasonography were performed.
28  hospital monitoring led to angiogram and/or intravascular ultrasonography, which confirmed thromboti
29 giographic coronary disease underwent serial intravascular ultrasonography while receiving statin tre